Bo Torben Porse

Medicine & Life Sciences

1. 23S Ribosomal RNA 54%
2. Acute Myeloid Leukemia 100%
3. Alternative Splicing 17%
4. Anti-Bacterial Agents 38%
5. CCAAT-Enhancer-Binding Protein-alpha 65%
6. CCAAT-Enhancer-Binding Proteins 28%
7. Chromatin Immunoprecipitation Sequencing 24%
8. Epigenomics 20%
9. Escherichia coli 30%
10. Gene Expression 32%
11. Genes 21%
12. Granulocyte Precursor Cells 31%
13. Granulocytes 23%
14. Growth 16%
15. Hematopoiesis 37%
16. Hematopoietic Stem Cells 53%
17. Histone Code 16%
18. Histones 23%
19. Leukemia 35%
20. Lipocalin-2 25%
21. Maintenance 23%
22. Messenger RNA 21%
23. Mutation 30%
24. Myeloid Cells 22%
25. Myeloid Leukemia 15%
26. Neoplasms 23%
27. Neutrophils 32%
28. Nonsense Mediated mRNA Decay 75%
29. Nucleotides 23%
30. Peptides 16%
31. Peptidyl Transferases 92%
32. Phenotype 15%
33. Polycomb Repressive Complex 2 24%
34. Polycomb-Group Proteins 18%
35. Proteins 22%
36. Regulator Genes 15%
37. ribosomal protein L11 22%
38. Ribosomes 55%
39. RNA Stability 20%
40. Sparsomycin 27%
41. Stem Cells 17%
42. Streptogramin A 16%
43. Streptogramin B 28%
44. Transcription Factors 45%
45. Transcriptome 35%
46. Transfer RNA 32%